- Early treatment with the antidepressant fluvoxamine prevents hospitalization of high-risk symptomatic adults with COVID-19 in the TOGETHER randomized, platform clinical trial.
Why this matters
- This study confirms a smaller randomized controlled trial.
- Fluvoxamine is an inexpensive treatment that will be highly useful in developing countries.
- Placebo-controlled, randomized,...